FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed treatments, today announced that Dr. Jan Egberts, NovaDel’s President and Chief Executive Officer, is scheduled to provide a corporate update at the upcoming Cowen and Company 27th Annual Health Care Conference to be held in Boston, MA. Details regarding NovaDel’s presentation at this event are as follows:
